Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Jonctum
2. N-acetyl Cis-4-hydroxy-l-proline
3. N-acetyl-4-hydroxyproline
4. N-acetylhydroxyproline
5. Oxaceprol, (cis)-isomer
6. Tejuntivo
1. 33996-33-7
2. N-acetyl-l-hydroxyproline
3. (2s,4r)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic Acid
4. Ac-hyp-oh
5. Jonctum
6. Oxaceprol [inn]
7. L-proline, 1-acetyl-4-hydroxy-, (4r)-
8. Trans-1-acetyl-4-hydroxy-l-proline
9. N-acetyl-trans-4-hydroxy-l-proline
10. Acetyl Hydroxyproline
11. Q0xv76b96l
12. Oxaceprol (inn)
13. (-)-1-acetyl-4-hydroxy-l-proline
14. N-acetylhydroxyproline
15. Dsstox_cid_26410
16. Dsstox_rid_81589
17. Dsstox_gsid_46410
18. Oxaceprolum
19. Tejuntivo
20. Mfcd00037339
21. Smr000857165
22. Cas-33996-33-7
23. Oxaceprolum [inn-latin]
24. Unii-q0xv76b96l
25. Ahp 200
26. Ncgc00164517-01
27. Einecs 251-780-6
28. Jonctum (tn)
29. (4r)-1-acetyl-4-hydroxy-l-proline
30. Oxaceprol [mi]
31. Acetyl-l-4-hydroxyproline
32. Oxaceprol [mart.]
33. Oxaceprol [who-dd]
34. Schembl25976
35. Mls001332445
36. Mls001332446
37. Chembl1407356
38. Dtxsid2046410
39. Hms2231j23
40. Zinc154540
41. Acetyl Hydroxyproline [inci]
42. Tox21_112152
43. Ab1252
44. Akos012536015
45. Akos015837714
46. Tox21_112152_1
47. Acetyl-4-hydroxy-l-proline, Trans-1-
48. Ccg-266379
49. Cs-5680
50. Db13363
51. Nalpha-acetyl-l-4-trans-hydroxyproline
52. Ncgc00274081-01
53. Hy-17490
54. Ts-00164
55. Db-009006
56. S3997
57. Trans-1-acetyl-4-hydroxy-l-proline, >=98%
58. D07215
59. 996a337
60. A822032
61. Q408948
62. W-106758
63. (2s)-1-acetyl-3-hydroxy-pyrrolidine-2-carboxylic Acid
64. (2s,4r)-1-acetyl-4-hydroxy-2-pyrrolidinecarboxylic Acid
65. (2s,4r)-1-acetyl-4-hydroxy-pyrrolidine-2-carboxylic Acid
66. 2235464-65-8
Molecular Weight | 173.17 g/mol |
---|---|
Molecular Formula | C7H11NO4 |
XLogP3 | -1.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 173.06880783 g/mol |
Monoisotopic Mass | 173.06880783 g/mol |
Topological Polar Surface Area | 77.8 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 216 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antirheumatic Agents
Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
D - Dermatologicals
D11 - Other dermatological preparations
D11A - Other dermatological preparations
D11AX - Other dermatologicals
D11AX09 - Oxaceprol
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AX - Other antiinflammatory and antirheumatic agents, non-steroids
M01AX24 - Oxaceprol
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?